Back to Search Start Over

Life under the CABOSUN: Cabozantinib improves quality‐adjusted survival in comparison with sunitinib

Authors :
Ravi A. Madan
Jeanny B. Aragon‐Ching
Source :
Cancer. 126:5210-5212
Publication Year :
2020
Publisher :
Wiley, 2020.

Subjects

Subjects :
Oncology
Cancer Research
medicine.medical_specialty
Cabozantinib
Sunitinib
business.industry
MEDLINE
medicine.disease
chemistry.chemical_compound
chemistry
Quality of life
Renal cell carcinoma
Internal medicine
Toxicity
medicine
Quality adjusted survival
business
Kidney cancer
medicine.drug

Details

ISSN :
10970142 and 0008543X
Volume :
126
Database :
OpenAIRE
Journal :
Cancer
Accession number :
edsair.doi...........f1d0847ba35e711f5a0fc7247c371e08
Full Text :
https://doi.org/10.1002/cncr.33168
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details